Patrick McCall - Dec 13, 2023 Form 4 Insider Report for IN8BIO, INC. (INAB)

Role
Chief Financial Officer
Signature
/s/ Jason Minio, Attorney-in-Fact
Stock symbol
INAB
Transactions as of
Dec 13, 2023
Transactions value $
$0
Form type
4
Date filed
12/15/2023, 08:23 AM
Previous filing
Aug 28, 2023
Next filing
Feb 8, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INAB Common Stock Award +20.5K +327.19% 26.8K Dec 13, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INAB Series A Warrants (right to buy) Award +20.5K 20.5K Dec 13, 2023 Common Stock 20.5K $1.25 Direct F1, F2
transaction INAB Series B Warrants (right to buy) Award +20.5K 20.5K Dec 13, 2023 Common Stock 20.5K $1.50 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported securities are included within 20,492 Issuer Units purchased by the Reporting Person for $1.22 per Unit. Each Unit consists of one share of common stock, one Series A warrant and one Series B warrant, each warrant represents the right to purchase 20,492 shares of common stock.
F2 Fully vested and exercisable.